Division of Hematology & Oncology

The Hematology/Oncology Division is devoted to state-of-the-art and compassionate treatment in malignant and non-malignant blood disorders, hemostasis and thrombosis, hematopoietic stem cell transplantation and cellular therapeutics, and solid tumor oncology. We are committed to improving care for tomorrow’s patients and have robust clinical trials and translational research programs. Our 35 hematologists/oncologists provide care at our outpatient facilities at the Emily Couric Clinical Cancer Center or in our Community Oncology sites in Fishersville, Culpeper, and Charlottesville (Pantops location). We provide comprehensive care in our inpatient Hematology/Oncology and stem cell units and on the hematology and oncology consultation services.

Experimental Treatment Sends Deadly Leukemia into Remission

Dr. Thomas P. Loughran Jr., director of the University of Virginia Cancer Center, discusses an experimental new treatment approach for a rare, deadly leukemia that can send the disease into remission even in patients for whom the standard therapy has failed, buying them more time to have the stem cell transplant that could save their lives.

Learn More

Michael E. Williams, Division of Hematology and Oncology

"I'm a clinical investigator in the University of Virginia Comprehensive Cancer Center, and I'm so grateful and excited to be involved in a field where there's been such dramatic progress in treatment options and cures for so many patients with cancer and blood disease."

Watch Video

UVA Cancer Center Enrolls First Patient in National Phase 1 Immunotherapy Trial

Led by Associate Professor of Hematology and Oncology Matthew Reilley, MD, the UVA Comprehensive Cancer Center (UVACCC) recently enrolled the first patient in a nationwide Phase 1 drug trial to evaluate a new immunotherapy drug’s potential to treat various forms of cancer.

Eric Hendrickson, PhD, Division of Hematology and Oncology

"I'm a Professor of Medicine in the Division of Hematology and Oncology, and my laboratory works on mammalian DNA double strand break repair, which is related to a variety of human disorders. Aging cancer, immune deficiencies."

Watch Video

Meet UVA Medical Oncologist, Dr. Ryan Gentzler

Dr. Gentzler’s clinical focus is the treatment of patients with lung cancer and other thoracic malignancies. His research is centered around the development of novel therapies for lung cancer. His goal is to contribute meaningful research that leads to improvements in the curability, survival, and quality of life for patients with lung cancer.

Watch Video

Meet UVA Hematologist/Oncologist, Karen Ballen, MD

Dr. Ballen is Division Chief of Hematology and Oncology, Section Head, Hematology and Stem Cell Transplantation, and Medical Director - Stem Cell Transplantation Program. Here research interests are in novel treatments for acute leukemia, stem cell transplantation, cord blood transplantation, haploidentical transplantation, immunotherapy treatment for hematologic malignancies.

Watch Video

Meet Hematologist Louise Man, MD

Dr. Man manages patients with a spectrum of benign hematological conditions. She has a clinical interest in quality improvement and a research interest in disorders of thrombosis and hemostasis.

Watch Video